Association of the clock genes polymorphisms with colorectal cancer susceptibility

Journal of Surgical Oncology

Volumn 108, Issue 8, 2013, Pages 563-567

  Karantanos, Theodoros ^a   Theodoropoulos, George ^a   Gazouli, Maria ^a   Vaiopoulou, Anna ^a   Karantanou, Christina ^a   Stravopodis, Dimitrios J ^b   Bramis, Konstantinos ^a   Lymperi, Maria ^a   Pektasidis, Dimitrios ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b UNIVERSITY OF ATHENS   (Greece)

Author keywords

circadian genes; colorectal cancer; polymorphisms

Indexed keywords

PER2 PROTEIN;

ADULT; AGED; ARTICLE; CANCER PROGNOSIS; CANCER STAGING; CANCER SURVIVAL; CANCER SUSCEPTIBILITY; CASE CONTROL STUDY; CLOCK 1 GENE; COLORECTAL CANCER; CONTROLLED STUDY; DNA EXTRACTION; FEMALE; GENE EXPRESSION; GENE FREQUENCY; GENETIC ASSOCIATION; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; ONCOGENE; PER 2 GENE; PER 3 GENE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

CIRCADIAN GENES; COLORECTAL CANCER; POLYMORPHISMS;

ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; CLOCK PROTEINS; COLORECTAL NEOPLASMS; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; PERIOD CIRCADIAN PROTEINS; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 84887473101     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.23434     Document Type: Article

References (30)

1. Chen-Goodspeed M, Lee CC:, Tumor suppression and circadian function. J Biol Rhythms 2007; 22: 291-298.
2. Kondratov RV, Chernov MV, Kondratova AA, et al.: BMAL1-dependent circadian oscillation of nuclear CLOCK: Posttranslational events induced by dimerization of transcriptional activators of the mammalian clock system. Genes Dev 2003; 17: 1921-1932. (Pubitemid 36944568)
3. DeBruyne JP, Weaver DR, Reppert SM:, CLOCK and NPAS2 have overlapping roles in the suprachiasmatic circadian clock. Nat Neurosci 2007; 10: 543-545. (Pubitemid 46652441)
4. Oshima T, Takenoshita S, Akaike M, et al.: Expression of circadian genes correlates with liver metastasis and outcomes in colorectal cancer. Oncol Rep 2011; 25: 1439-1446.
5. Mullenders J, Fabius AW, Madiredjo M, et al.: A large scale shRNA barcode screen identifies the circadian clock component ARNTL as putative regulator of the p53 tumor suppressor pathway. PLoS ONE 2009; 4: e4798.
6. Gery S, Komatsu N, Baldjyan L, et al.: The circadian gene per1 plays an important role in cell growth and DNA damage control in human cancer cells. Mol Cell 2006; 3: 375-3382.
7. Alhopuro P, Björklund M, Sammalkorpi H, et al.: Mutations in the circadian gene CLOCK in colorectal cancer. Mol Cancer Res 2010; 8: 952-960.
8. Gu X, Xing L, Shi G, et al.: The circadian mutation PER2(S662G) is linked to cell cycle progression and tumorigenesis. Cell Death Differ 2012; 19: 397-405.
9. Fu L, Pelicano H, Liu J, et al.: The circadian gene Period2 plays an important role in tumor suppression and DNA damage response in vivo. Cell 2002; 111: 41-50.
10. Gery S, Koeffler HP:, The role of circadian regulation in cancer. Cold Spring Harb Symp Quant Biol 2007; 2: 459-464.
11. Gery S, Virk RK, Chumakov K, et al.: The clock gene Per2 links the circadian system to the estrogen receptor. Oncogene 2007; 26: 7916-7920. (Pubitemid 350262755)
12. Climent J, Perez-Losada J, Quigley DA, et al.: Deletion of the PER3 gene on chromosome 1p36 in recurrent ER-positive breast cancer. J Clin Oncol 2010; 28: 3770-3778.
13. Aaltonen LA, Salovaara R, Kristo P, et al.: Incidence of hereditary nonpolyposis colorectal cancer and the feasibility of molecular screening for the disease. N Engl J Med 1998; 338: 1481-1487. (Pubitemid 28226275)
14. Loeb LA:, A mutator phenotype in cancer. Cancer Res 2001; 61: 3230-3239. (Pubitemid 32695004)
15. Zhou F, He X, Liu H, et al.: Functional polymorphisms of circadian positive feedback regulation genes and clinical outcome of Chinese patients with resected colorectal cancer. Cancer 2012; 118: 937-946.
16. Wang Y, Hua L, Lu C, et al.: Expression of circadian clock gene human Period2 (hPer2) in human colorectal carcinoma. World J Surg Oncol 2011; 9: 166-170.
17. Zeman M, Vician M, Monosíková J, et al.: Deregulated expression of the per2 gene in human colorectal carcinoma. Mol Med Rep 2008; 1: 599-603.
18. Wang X, Yan D, Teng M, et al.: Reduced expression of PER3 is associated with incidence and development of colon cancer. Ann Surg Oncol 2012; 19: 3081-3088.
19. Jemal A, Siegel R, Xu J, et al.: Cancer statistics. CA Cancer J Clin 2010; 60: 277-300.
20. Compton CC, Fielding LP, Burgart LJ, et al.: Prognostic factors in colorectal cancer. College of American Pathologists Consensus Statement 1999. Arch Pathol Lab Med 2000; 124: 979-994. (Pubitemid 30602039)
21. Chang GJ, Hu CY, Eng C, et al.: Practical application of a calculator for conditional survival in colon cancer. J Clin Oncol 2009; 27: 5938-5943.
22. Lee HJ, Kim L, Kang SG, et al.: PER2 variation is associated with diurnal preference in a Korean young population. Behav Genet 2011; 41: 273-277.
23. Zhu Y, Brown HN, Zhang Y, et al.: Period 3 structural variation: A circadian biomarker associated with breast cancer in young women. Cancer Epidemiol Biomarkers Prev 2005; 14: 268-270. (Pubitemid 40165313)
24. Morson BC, Sobin LH:, Histologic typing of intestinal tumours: WHO technical report. Geneva: WHO; 1976.
25. Sobin LH, Wittekind C, editors: UICC TNM classification of malignant tumours. 5th edition. New York: Wiley; 1997.
26. Malison RT, Kranzler HR, Yang BZ, et al.: Human clock, PER1 and PER2 polymorphisms: Lack of association with cocaine dependence susceptibility and cocaine-induced paranoia. Psychiatr Genet 2006; 16: 245-249. (Pubitemid 44760304)
27. Theodoropoulos GE, Gazouli M, Vaiopoulou A, et al.: Polymorphisms of caspase 8 and caspase 9 gene and colorectal: Susceptibility and prognosis. Int J Colorectal Dis 2011; 26: 1113-1118.
28. Karantanos T, Theodoropoulos G, Gazouli M:, et al.: Expression of clock genes in patients with colorectal cancer. Int J Biol Markers 2013; [Epub ahead of print].
29. Mazzoccoli G, Panza A, Valvano MR, et al.: Clock gene expression levels and relationship with clinical and pathological features in colorectal cancer patients. Chronobiol Int 2011; 28: 841-851.
30. Archer SN, Robilliard DL, Skene DJ, et al.: A length polymorphism in the circadian clock gene Per3 is linked to delayed sleep phase syndrome and extreme diurnal preference. Sleep 2003; 26: 413-415. (Pubitemid 39610658)